Know Cancer

or
forgot password
  • cancer clinical trials in rhode island

  • Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Extensive Stage Small Cell Lung Cancer
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    University Urological Research Institute
    Providence, Rhode Island 02904
    Prostate Cancer, Osteoporosis, Fractures
    Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Leukemia, Lymphoma, Tumor Lysis Syndrome, Hyperuricemia
    An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Providence, Rhode Island 02905
    Genital Neoplasms, Female, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pelvic Neoplasms, Peritoneal Neoplasms
    A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients
    Duramed Investigational Site
    Providence, Rhode Island 02904
    Prostate Cancer
    Skills and Motivation at the Rhode Island Training School (Project SMART) - 1
    University of Rhode Island

    Trial Locations
    University of Rhode Island
    University of Rhode Island, Cancer Prevention Research Center
    Substance-Related Disorders
    Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.
    GSK Investigational Site
    Cranston, Rhode Island 02920
    Human Papillomavirus (HPV) Infection, Cervical Neoplasia
    Motivational Program for Smokers Enrolled in a Methadone Maintenance Program
    Rhode Island Hospital Comprehensive Cancer Center
    Providence, Rhode Island 02903
    Unspecified Adult Solid Tumor, Protocol Specific
    Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.
    Women & Infants' Hospital
    Providence, Rhode Island 02905
    Ovarian Cancer, Breast Cancer
    Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
    Women & Infants Hospital
    Providence, Rhode Island 02905-2499
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
    University Urological Research Institute

    Trial Locations
    University Urological Research Institute
    Univeristy Urological Research Institute
    Prostate Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Hematology and Oncology Associates of Rhode Island Inc

    Trial Locations
    Hematology and Oncology Associates of Rhode Island Inc
    Kent County Hospital
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
    Roger Williams Medical Center
    Providence, Rhode Island 02908-4735
    Oral Mucositis, Stomatitis
    BC-DAISY: A Breast Cancer Decision Aid System
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Breast Cancer
    Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Fallopian Tube Cancer, Infection, Neutropenia, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Rhode Island Hospital
    Providence, Rhode Island 02903
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Atrial Fibrillation, Atrial Flutter
    A Study for Patients With Head and Neck Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Providence, Rhode Island 02905
    Head and Neck Neoplasms
    Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Ovarian Cancer
    A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment
    Women & Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer
    Expanded Access Program for Maraviroc At Multiple Centers
    Pfizer Investigational Site
    Providence, Rhode Island 02906
    Advanced HIV Infection
    A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema
    Brown University Oncology Group
    Providence, Rhode Island 02912
    Metastatic Pancreatic Cancer
    BrUOG-EG-203 Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal, Gastroesophageal Junction and Gastric Cancer
    Brown University Oncology Group
    Providence, Rhode Island 02912
    Esophageal Cancer, Gastric Cancer
    BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer
    Lifespan Hospitals
    Providence, Rhode Island 02903
    Metastatic Pancreatic Cancer
    Assessment and Tracking of Long-term Alefacept Safety
    Clinical Partners, LLC

    Trial Locations
    Clinical Partners, LLC
    Paul T. Zaydon MD
    Psoriasis
    Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
    Rhode Island Hospital Comprehensive Cancer Center
    Providence, Rhode Island 02903
    Sarcoma
    Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Squamous Cell Carcinoma
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Rhode Island Hospital Comprehensive Cancer Center
    Providence, Rhode Island 02903
    Leukemia
    Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Cervical Cancer
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Barrett's Esophagus, High Grade Dysplasia, Low Grade Dysplasia
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    Rhode Island Hospital and The Neurology Foundation, Inc
    Providence, Rhode Island
    Multiple Sclerosis, Relapsing-Remitting
    Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
    Pfizer Investigational Site
    Providence, Rhode Island 02906
    Ewing's Sarcoma Family of Tumors
    Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
    Sanofi-Aventis Investigational Site Number 840082

    Trial Locations
    Sanofi-Aventis Investigational Site Number 840082
    Sanofi-Aventis Investigational Site Number 840095
    Colorectal Neoplasms, Neoplasm Metastasis
    Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Cervical Cancer, Endometrial Cancer, Lymphedema, Vulvar Cancer
    MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ
    Rhode Island Hospital
    Providence, Rhode Island 02903
    DCIS
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 075
    Warwick, Rhode Island 02886
    Hypoactive Sexual Desire Disorder
    Pilot Study on Laser Ablation of Symptomatic Benign Thyroid Masses
    Rhode Island Hospital - Department of Diagnostic Imaging Research
    Providence, Rhode Island 02903
    Thyroid Nodule, Thyroid Cancer, Thyroid Neoplasms, Nodular Goiter
    A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
    Landmark Medical Center
    Woonsocket, Rhode Island 02895
    Myelodysplastic Syndrome
    Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
    Sanofi-Aventis Investigational Site Number 840058
    Woonsocket, Rhode Island 02895
    Urinary Bladder Neoplasms
    A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
    Research Site
    Pawtucket, Rhode Island
    Adenocarcinoma of the Pancreas, Metastatic Pancreatic Cancer, Pancreatic Cancer
    Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Severe Sepsis
    Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
    Pharma Resource
    East Providence, Rhode Island 02915
    MDS, AML, Solid Tumors, Multiple Myeloma, Non-Hodgkin's Lymphoma, Hodgkin's Disease
    A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer
    Research Site
    Pawtucket, Rhode Island
    Bladder Cancer, Transitional Cell Bladder Cancer, Urethra Cancer, Ureter Cancer, Renal Pelvis Cancer
    Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    ChemoFx® PRO - A Post-Market Data Collection Study
    Women & Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer
    Dasatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Trial of Second Generation Designer T Cells in Colorectal Carcinoma
    Roger Williams Medical Center
    Providence, Rhode Island 02908-4735
    Colorectal Cancer
    Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy
    Investigational Site Number 840075
    East Providence, Rhode Island 02915
    Venous Thromboembolism, Cancer